Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1997 Oct 1;327(Pt 1):89–94. doi: 10.1042/bj3270089

Expression, purification and characterization of recombinant caprine N-acetylglucosamine-6-sulphatase.

T Litjens 1, J Bielicki 1, D S Anson 1, K Friderici 1, M Z Jones 1, J J Hopwood 1
PMCID: PMC1218767  PMID: 9355739

Abstract

Mucopolysaccharidosis type IIID or Sanfilippo D syndrome is a lysosomal storage disorder caused by the deficiency of N-acetylglucosamine-6-sulphatase (Glc6S). In addition to human patients, a Nubian goat with this disorder has been described and the caprine Glc6S (cGlc6S) cDNA cloned. In this study, the full-length cGlc6S cDNA was inserted into the expression vector, pEFNeo, which placed the cGlc6S cDNA under the transcriptional control of the human polypeptide chain elongation factor promoter. The pEFNeo expression vector also contains the human growth hormone polyadenylation signal and the genes encoding resistance to ampicillin and G418. The cGlc6S expression construct was electroporated into Chinese hamster ovary (CHO-K1) cells, and stably transfected clones were isolated. One clone, CHOrcGlc6S.17, which secreted the highest Glc6S activity into the culture medium, was selected and cultured in cell factories. The secreted recombinant cGlc6S (rcGlc6S) precursor was purified to homogeneity from conditioned medium by a two-column procedure which consisted of a Cu2+-chelating Sepharose column followed by TSK G3000SW gel filtration. The native molecular mass of rcFlc6S was estimated to be 102 kDa and the subunit size was 94 kDa. The kinetic properties of cGlc6S were similar to those of human Glc6S isolated from liver. rcGlc6S was endocytosed by fibroblasts from patients with mucopolysaccharidosis type IIID via the mannose 6-phosphate receptor-mediated pathway resulting in correction of the storage phenotype of these cells.

Full Text

The Full Text of this article is available as a PDF (313.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anson D. S., Taylor J. A., Bielicki J., Harper G. S., Peters C., Gibson G. J., Hopwood J. J. Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Biochem J. 1992 Jun 15;284(Pt 3):789–794. doi: 10.1042/bj2840789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Basner R., Kresse H., von Figura K. N-Acetylglucosamine-6-sulfate sulfatase from human urine. J Biol Chem. 1979 Feb 25;254(4):1151–1158. [PubMed] [Google Scholar]
  3. Bielicki J., Freeman C., Clements P. R., Hopwood J. J. Human liver iduronate-2-sulphatase. Purification, characterization and catalytic properties. Biochem J. 1990 Oct 1;271(1):75–86. doi: 10.1042/bj2710075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bielicki J., Fuller M., Guo X. H., Morris C. P., Hopewood J. J., Anson D. S. Expression, purification and characterization of recombinant human N-acetylgalactosamine-6-sulphatase. Biochem J. 1995 Oct 1;311(Pt 1):333–339. doi: 10.1042/bj3110333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bielicki J., Hopwood J. J., Anson D. S. Correction of Sanfilippo A skin fibroblasts by retroviral vector-mediated gene transfer. Hum Gene Ther. 1996 Oct 20;7(16):1965–1970. doi: 10.1089/hum.1996.7.16-1965. [DOI] [PubMed] [Google Scholar]
  6. Bielicki J., Hopwood J. J., Wilson P. J., Anson D. S. Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme. Biochem J. 1993 Jan 1;289(Pt 1):241–246. doi: 10.1042/bj2890241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cavanagh K. T., Leipprandt J. R., Jones M. Z., Friderici K. Molecular defect of caprine N-acetylglucosamine-6-sulphatase deficiency. A single base substitution creates a stop codon in the 5'-region of the coding sequence. J Inherit Metab Dis. 1995;18(1):96–96. doi: 10.1007/BF00711390. [DOI] [PubMed] [Google Scholar]
  8. Chang P. L., Ameen M., Yu C. Z., Kelly B. M. Effect of ammonium chloride on subcellular distribution of lysosomal enzymes in human fibroblasts. Exp Cell Res. 1988 Jun;176(2):258–267. doi: 10.1016/0014-4827(88)90329-1. [DOI] [PubMed] [Google Scholar]
  9. Clements P. R., Muller V., Hopwood J. J. Human alpha-L-iduronidase. 2. Catalytic properties. Eur J Biochem. 1985 Oct 1;152(1):29–34. doi: 10.1111/j.1432-1033.1985.tb09159.x. [DOI] [PubMed] [Google Scholar]
  10. Crawley A. C., Brooks D. A., Muller V. J., Petersen B. A., Isaac E. L., Bielicki J., King B. M., Boulter C. D., Moore A. J., Fazzalari N. L. Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome. J Clin Invest. 1996 Apr 15;97(8):1864–1873. doi: 10.1172/JCI118617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dorner A. J., Wasley L. C., Kaufman R. J. Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells. J Biol Chem. 1989 Dec 5;264(34):20602–20607. [PubMed] [Google Scholar]
  12. Freeman C., Clements P. R., Hopwood J. J. Human liver N-acetylglucosamine-6-sulphate sulphatase. Purification and characterization. Biochem J. 1987 Sep 1;246(2):347–354. doi: 10.1042/bj2460347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Freeman C., Hopwood J. J. Human liver N-acetylglucosamine-6-sulphate sulphatase. Catalytic properties. Biochem J. 1987 Sep 1;246(2):355–365. doi: 10.1042/bj2460355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Freeman C., Hopwood J. J. Human liver glucuronate 2-sulphatase. Purification, characterization and catalytic properties. Biochem J. 1989 Apr 1;259(1):209–216. doi: 10.1042/bj2590209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Friderici K., Cavanagh K. T., Leipprandt J. R., Traviss C. E., Anson D. S., Hopwood J. J., Jones M. Z. Cloning and sequence analysis of caprine N-acetylglucosamine 6-sulfatase cDNA. Biochim Biophys Acta. 1995 Jun 9;1271(2-3):369–373. doi: 10.1016/0925-4439(95)00054-8. [DOI] [PubMed] [Google Scholar]
  16. Fukuta M., Okada H., Iinuma S., Yanai S., Toguchi H. Insulin fragments as a carrier for peptide delivery across the blood-brain barrier. Pharm Res. 1994 Dec;11(12):1681–1688. doi: 10.1023/a:1018942728317. [DOI] [PubMed] [Google Scholar]
  17. Hasilik A. The early and late processing of lysosomal enzymes: proteolysis and compartmentation. Experientia. 1992 Feb 15;48(2):130–151. doi: 10.1007/BF01923507. [DOI] [PubMed] [Google Scholar]
  18. He W., Voznyi YaV, Boer A. M., Kleijer W. J., van Diggelen O. P. A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease type D (MPS IIID). J Inherit Metab Dis. 1993;16(6):935–941. doi: 10.1007/BF00711508. [DOI] [PubMed] [Google Scholar]
  19. Hopwood J. J., Elliott H., Muller V. J., Saccone G. T. Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity. Biochem J. 1986 Mar 15;234(3):507–514. doi: 10.1042/bj2340507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kresse H., Paschke E., von Figura K., Gilberg W., Fuchs W. Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6822–6826. doi: 10.1073/pnas.77.11.6822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. LEABACK D. H., WALKER P. G. Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase. Biochem J. 1961 Jan;78:151–156. doi: 10.1042/bj0780151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  23. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  24. Robertson D. A., Callen D. F., Baker E. G., Morris C. P., Hopwood J. J. Chromosomal localization of the gene for human glucosamine-6-sulphatase to 12q14. Hum Genet. 1988 Jun;79(2):175–178. doi: 10.1007/BF00280560. [DOI] [PubMed] [Google Scholar]
  25. Robertson D. A., Freeman C., Morris C. P., Hopwood J. J. A cDNA clone for human glucosamine-6-sulphatase reveals differences between arylsulphatases and non-arylsulphatases. Biochem J. 1992 Dec 1;288(Pt 2):539–544. doi: 10.1042/bj2880539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sands M. S., Vogler C., Kyle J. W., Grubb J. H., Levy B., Galvin N., Sly W. S., Birkenmeier E. H. Enzyme replacement therapy for murine mucopolysaccharidosis type VII. J Clin Invest. 1994 Jun;93(6):2324–2331. doi: 10.1172/JCI117237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shull R. M., Kakkis E. D., McEntee M. F., Kania S. A., Jonas A. J., Neufeld E. F. Enzyme replacement in a canine model of Hurler syndrome. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12937–12941. doi: 10.1073/pnas.91.26.12937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Taylor R. M., Stewart G. J., Farrow B. R., Byrne J., Healy P. J. Histological improvement and enzyme replacement in the brains of fucosidosis dogs after bone marrow engraftment. Transplant Proc. 1989 Feb;21(1 Pt 3):3074–3075. [PubMed] [Google Scholar]
  29. Thompson J. N., Jones M. Z., Dawson G., Huffman P. S. N-acetylglucosamine 6-sulphatase deficiency in a Nubian goat: a model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID). J Inherit Metab Dis. 1992;15(5):760–768. doi: 10.1007/BF01800018. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES